H. Rogers

发表

Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.

F. Juma, H. Rogers, J. Trounce, 1979, British journal of clinical pharmacology.

Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites

F. Juma, H. Rogers, J. Trounce, 2004, European Journal of Clinical Pharmacology.

Rifampicin reduces effectiveness and bioavailability of prednisolone.

P. Thompson, H. Rogers, W. Mcallister, 1983, British medical journal.

Biliary elimination of cyclophosphamide in man

J. Dooley, R. Stuart-Harris, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography

F. Juma, H. Rogers, J. Trounce, 2004, Cancer Chemotherapy and Pharmacology.

The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients.

N. Thatcher, L. Lewis, P. Harper, 1991, British journal of clinical pharmacology.

Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism.

L. Lewis, P. Harper, H. Rogers, 1990, British journal of clinical pharmacology.

Rapid gas chromatographic determination of ifosfamide in biological fluids.

H. Rogers, M. Talha, 1984, Journal of chromatography.

The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.

F. Juma, H. Rogers, J. Trounce, 1980, British journal of clinical pharmacology.

The kinetics of salivary elimination of cyclophosphamide in man.

F. Juma, H. Rogers, J. Trounce, 1979, British journal of clinical pharmacology.

Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets

H. Rogers, S. Al-Habet, 2004, European Journal of Clinical Pharmacology.

Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.

P. Crome, H. Rogers, I. Bradbrook, 1986, British journal of clinical pharmacology.

Comparative Transport Activity of Intact Cells, Membrane Vesicles, and Mesosomes of Bacillus licheniformis

R. Macleod, H. Rogers, P. Thurman, 1973, Journal of bacteriology.

Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.

H. Rogers, I. Bradbrook, P. Morrison, 1983, The Journal of antimicrobial chemotherapy.

Autolytic enzyme-deficient mutants of Bacillus subtilis 168

J. Fein, H. Rogers, 1976, Journal of bacteriology.

The influence of cimetidine on debrisoquine 4-hydroxylation in extensive metabolizers

P. Philip, H. Rogers, C. James, 2004, European Journal of Clinical Pharmacology.

Mapping of rod Mutants of Bacillus subtilis

D. Karamata, H. Rogers, M. McConnell, 1972, Journal of bacteriology.

4 – Drugs and Intracellular Control Mechanisms

H. Rogers, 1976 .

Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.

H. Rogers, M. Vandenburg, R. Ahmad, 1981, British journal of clinical pharmacology.

The effects of domperidone on the absorption of levodopa in normal subjects

H. Rogers, I. Bradbrook, H. Gillies, 2004, European Journal of Clinical Pharmacology.

Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method

H. Rogers, R. Ahmad, 1980, European Journal of Clinical Pharmacology.

Plasma mexiletine concentrations following combined oral and intramuscular administration

H. Rogers, I. Bradbrook, P. Morrison, 1981, European Journal of Clinical Pharmacology.

Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release.

H. Rogers, V. John, I. Bradbrook, 1985, British journal of clinical pharmacology.

Effect of pirprofen on glibenclamide kinetics and response.

H. Rogers, V. John, I. Bradbrook, 1982, British journal of clinical pharmacology.

Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.

H. Rogers, R. Ahmad, 1980, British journal of clinical pharmacology.

Pharmacokinetics of intravenous and oral prednisolone.

H. Rogers, S. Al-Habet, 1980, British journal of clinical pharmacology.

Effect of cimetidine on the absorption of orally administered tetracycline.

F. House, H. Rogers, I. Bradbrook, 1980, British journal of clinical pharmacology.

Kinetics of single doses of fenbufen in patients with renal insufficiency

H. Rogers, R. Spector, J. Savitsky, 1981, Clinical pharmacology and therapeutics.

Phase II trial of idarubicin in patients with advanced lymphoma

S. Johnson, P. Harper, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Effect of cancer chemotherapy on dapsone N-acetylation in man

P. Philip, P. Harper, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma

H. Rogers, R. Ahmad, I. A. Taha, 2004, Cancer Chemotherapy and Pharmacology.

360. Gallotannins. Part III. The constitution of Chinese, Turkish, sumach, and tara tannins

R. D. Haworth, E. Haslam, H. Rogers, 1961 .

Bacterial Cell Structure

H. Rogers, 1983 .

Uroepithelial and nephrotubula toxicity in patients receiving ifosfamide/mesna: Measurement of urinary N-acetyl-β-d-glucosaminidase and β-2-microglobulin

L. Lewis, P. Harper, H. Rogers, 1992 .

Action of Plasmin on Cartilage

H. Rogers, H. Rogers, C. Lack, 1958, Nature.

ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.

T. van Dinther, H. Magnani, H. Rogers, 1987, British journal of clinical pharmacology.

Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid Chromatographic assay

H. Rogers, I. Bradbrook, P. Morrison, 1982, Diabetologia.

Methylprednisolone pharmacokinetics after intravenous and oral administration.

H. Rogers, S. Al-Habet, 1989, British journal of clinical pharmacology.

The chemistry of the cell walls of rod mutants of Bacillus subtilis.

H. Rogers, R. Hughes, M. McConnell, 1971, Journal of general microbiology.

Cell Wall or Membrane Mutants of Bacillus subtilis and Bacillus licheniformis with Grossly Deformed Morphology

H. Rogers, I. Burdett, H. Rogers, 1968, Nature.

2 – The Mode of Action of Some Antibacterial Substances

H. Rogers, 1964 .

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.

P. Harper, H. Rogers, K. Ohashi, 1987, British journal of clinical pharmacology.

The role of L-glutamine in the phenotypic change of a rod mutant derived from Bacillus subtilis 168.

H. Rogers, M. McConnell, 1970, Journal of general microbiology.

Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.

H. Rogers, I. Bradbrook, P. Morrison, 1977, British journal of clinical pharmacology.

Concentration and Distribution of Polysaccharides in Human Cortical Bone and the Dentine of Teeth

H. Rogers, 1949, Nature.

Protein‐carbohydrate interactions in biological systems the molecular biology of microbial pathogenicity

H. Rogers, 1987 .

Morphological and cell wall alterations in thermosensitive DNA mutants of Bacillus subtilis.

D. Karamata, H. Rogers, J. Viret, 1985, Annales de l'Institut Pasteur. Microbiologie.

Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects.

H. Rogers, I. Bradbrook, H. Gillies, 1985, British journal of clinical pharmacology.

Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection.

H. Rogers, A. Bye, D. Brigden, 1981, The Journal of antimicrobial chemotherapy.

The effects of flurbiprofen and indomethacin on the mitogenic response of human peripheral mononuclear cells.

H. Rogers, A. Jawad, 1984, Immunopharmacology.

Role of Autolysins in the Killing of Bacteria by Some Bactericidal Antibiotics

C. Forsberg, H. Rogers, 1971, Journal of bacteriology.

Mucopeptide synthesis by rod mutants of Bacillus subtilis.

J. Reeve, H. Rogers, P. Thurman, 1974, Journal of general microbiology.

Bacterial growth and the cell envelope.

H. Rogers, 1970, Bacteriological reviews.

The isolation and characterization of mutants of Bacillus subtilis and Bacillus licheniformis with disturbed morphology and cell division.

I. Burdett, H. Rogers, M. McConnell, 1970, Journal of general microbiology.

The Bactericidal Action of P-Lactam Antibiotics on an Autolysin-deficient Strain of Bacillus subtilis By

H. Rogers, 2022 .

Genetically determined debrisoquine oxidation capacity in bladder cancer.

P. Philip, H. Rogers, R. Cartwright, 1984, Carcinogenesis.

Biosynthesis of Hyaluronate

H. Rogers, H. Rogers, D. A. Lowther, 1955, Nature.

The isolation and characteristics of an organism oxidizing thiocyanate.

J. Youatt, H. Rogers, F. Happold, 1954, Journal of general microbiology.

Decreased systemic clearance of caffeine due to cimetidine.

H. Rogers, L. Broughton, 1981, British journal of clinical pharmacology.

Purification and properties of autolytic endo-beta-N-acetylglucosaminidase and the N-acetylmuramyl-L-alanine amidase from Bacillus subtilis strain 168.

J. Ward, H. Rogers, S. Rayter, 1984, Journal of general microbiology.

9 – Circulatory System

H. Rogers, 1976 .

Inhibition of cell-wall-muco-peptide formation in Escherichia coli by benzylpenicillin and 6-[D(-)-alpha-aminophenylacetamido]penicillanic acid (ampicillin).

J. Mandelstam, H. Rogers, 1962, The Biochemical journal.

Inhibition of the biosynthesis of cell-wall mucopeptides by the penicillins. A study of penicillin-sensitive and penicillin-resistant strains of Staphylococcus aureus.

J. Jeljaszewicz, H. Rogers, 1961, The Biochemical journal.

Double Mutants of Bacillus subtilis Growing as Helices

H. Rogers, P. Thurman, 1978, Journal of bacteriology.

Ultrastructural study of the reversion of protoplasts of Bacillus licheniformis to bacilli

J. Ward, H. Rogers, T. Elliott, 1975, Journal of bacteriology.

The inhibition of mucopeptide synthesis by benzylpenicillin in relation to irreversible fixation of the antibiotic by staphylococci.

H. Rogers, 1967, The Biochemical journal.

Distribution and pharmacokinetics of cyclophosphamide in the rat.

H. Rogers, J. Trounce, M. Talha, 1980, British Journal of Cancer.

Initial controlled evaluation of antihypertensive drugs : a study with indapamide

P. Turner, G. Volans, H. Rogers, 1977 .

359. Gallotannins. Part II. Some esters and depsides of gallic acid

R. D. Haworth, E. Haslam, H. Rogers, 1961 .

Influence of age, sex and body weight on the dapsone acetylation phenotype.

P. Philip, P. Crome, H. Rogers, 1987, British journal of clinical pharmacology.

The involvement of proteases in the morphogenesis of rod mutants of Bacillus subtilis

H. Rogers, H. Rogers, P. Thurman, 1980, FEBS letters.

A Textbook of Clinical Pharmacology

H. Rogers, J. Trounce, H. C. Gillies, 1981 .

Effect of paracetamol on amylobarbitone hydroxylation in man: a gas chromatographic method for simultaneous estimation of underivatized paracetamol and barbiturates

P. Toseland, H. Rogers, H. Kinsella, 1979, The Journal of pharmacy and pharmacology.

THE EFFECT OF STERILISATION UPON SUGARS

H. Rogers, J. G. Davis, 1938 .

CHAPTER 5 – The Dissimilation of High Molecular Weight Substances

H. Rogers, 1961 .

Pharmacokinetic observations on dapsone in dermatitis herpetiformis

H. Rogers, L. Fry, J. Leonard, 1983, The British journal of dermatology.

Metabolism of Aflatoxin in Sheep: Excretion of the ‘Milk Toxin’

H. Rogers, G. Lewis, R. Allcroft, 1966, Nature.

PYRIMETHAMINE/DAPSONE RESISTANT FALCIPARUM MALARIA IMPORTED FROM KENYA

D. Warhurst, H. Rogers, H. Lambert, 1982, The Lancet.

An analysis of the products formed during the hydrolysis of hyaluronate by enzymes and acids, with observations on the nature of the amino-sugar released from the polysaccharide.

H. Rogers, 1946, The Biochemical journal.

The influence of hydrolysates of hyaluronate upon hyaluronidase production by micro-organisms.

H. Rogers, 1946, The Biochemical journal.

The conditions controlling the production of hyaluronidase by micro-organisms grown in simplified media.

H. Rogers, 1945, The Biochemical journal.

Enzyme Inhibition

H. Rogers, P. Spensley, 1954, Nature.

Possible intermediates in the biosynthesis of mycoside B by Mycobacterium microti.

A. M. Lawson, W. Chai, H. Rogers, 1993, European journal of biochemistry.

Effects of Ethanol and Other 1-Alkanols on Cell Autolysis and Macromolecular Synthesis by Bacillus subtilis

H. Rogers, G. Wright, 1986 .

Synthetic polyanionic inhibitors of hyaluronidase.

H. Rogers, P. Spensley, 1954, Biochimica et biophysica acta.

Formation of cell wall polymers by reverting protoplasts of Bacillus licheniformis

J. Ward, H. Rogers, T. Elliott, 1975, Journal of bacteriology.

The in vitro effect of trimethoprim on blastogenic transformation of human peripheral blood lymphocytes.

P. Lietman, H. Rogers, 1977, Biochemical pharmacology.

Effect of Phosphate Limitation on the Morphology and Wall Composition of Bacillus licheniformis and Its Phosphoglucomutase-Deficient Mutants

C. Forsberg, J. Ward, H. Rogers, 1973, Journal of bacteriology.

Characterization of Bacillus licheniformis 6346 Mutants Which Have Altered Lytic Enzyme Activities

C. Forsberg, H. Rogers, 1974, Journal of bacteriology.

Three-dimensional molecular models of bacterial cell wall mucopeptides (peptidoglycans).

H. Rogers, M. V. Kelemen, 1971, Proceedings of the National Academy of Sciences of the United States of America.

Malabsorption of prednisolone from enteric-coated tablets after ileostomy.

H. Rogers, J. Trounce, S. Al-Habet, 1980, British medical journal.

Genetic Transfer of the Stable L Form State to Intact Bacterial Cells

H. Rogers, P. Wyrick, M. McConnell, 1973, Nature.

Plasma and salivary pharmacokinetics of caffeine in man

M. Lind, H. Rogers, I. Bradbrook, 2004, European Journal of Clinical Pharmacology.

12 – The Alimentary System

H. Rogers, 1976 .

Relations between structure and function in the prokaryotic cell

R. Stanier, J. Ward, H. Rogers, 1978 .

Autolytic Enzymes in Growth of Bacteria

C. Forsberg, H. Rogers, 1971, Nature.

Isolation and Characterization of Cell Wall-Defective Variants of Bacillus subtilis and Bacillus licheniformis

H. Rogers, P. Wyrick, 1973, Journal of bacteriology.

Diphenylhydantoin diazepam interactions: a pharmacokinetic analysis

P. Lietman, H. Rogers, Robert H. A. Haslam, 1975 .

Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients.

A. Woolf, H. Rogers, I. Bradbrook, 1983, British journal of clinical pharmacology.

The structure and function of hyaluronate.

H. Rogers, 1961, Biochemical Society symposium.

The influence of psychotropic drugs on aldolase, mitochondrial malic dehydrogenase and Mg++Na+K+ adenosine triphosphatase

H. Rogers, D. Watts, R. Spector, 1969, British journal of pharmacology.

Aids to pharmacology

R. Spector, H. Rogers, 1980 .

Phenytoin intoxication during concurrent diazepam therapy

J. Longstreth, P. Lietman, H. Rogers, 1977, Journal of neurology, neurosurgery, and psychiatry.

Relationship between hypothermia and some chlorpromazine induced metabolic changes in mouse brain

H. Rogers, 1972, Experientia.

A rapid method for the determination of plasma mexiletine levels by gas chromatography.

H. Rogers, C. James, I. Bradbrook, 1977, British journal of clinical pharmacology.

Single-dose pharmacokinetic and pharmacodynamic comparison of polymer-matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.

P. Turner, H. Rogers, V. John, 1985, British journal of clinical pharmacology.

A Simple Confirmatory Medium for Str. Agalactiae

H. Rogers, J. G. Davis, 1939 .

209. Studies in mastitis. I. The routine diagnosis of mastitis

H. Rogers, J. G. Davis, J. Mcclemont, 1939, Journal of Dairy Research.

N-Acetyltransferase phenotypes in Iraqi and British population.

H. Rogers, R. Cartwright, R. Ahmad, 1984, Human heredity.

Ifosfamide plasma clearance in relation to polymorphic debrisoquine oxidation

P. Philip, L. Lewis, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.

H. Rogers, C. James, T. Mant, 1987, British journal of clinical pharmacology.

Production and purification of bacilysin.

E. Abraham, H. Rogers, G. G. Newton, 1965, Biochemical Journal.

Pharmacokinetics of melphalan in children following high-dose intravenous injection

D. Rogers, H. Rogers, R. Ahmad, 1983, Cancer Chemotherapy and Pharmacology.

Observations on the structure of bacilysin.

E. Abraham, H. Rogers, N. Lomakina, 1965, The Biochemical journal.

Inverse Relationship between Formation of Phenotypically Recombinant Clones and Cell Wall Regeneration after Fusion of Bacillus subtilis Protoplasts

P. Schaeffer, H. Rogers, B. Savelli, 1985 .

A phase II study of ifosfamide in children with recurrent solid tumours

O. Eden, A. Bowman, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Melphalan estimation by quantitative thin-layer chromatography

H. Rogers, RaadA. Ahmad, Ibtisam A.-K. Taha, 1981, Cancer Chemotherapy and Pharmacology.

The influence of aromatic amines and folate on acid production byEscherichia coli

H. Rogers, R. Spector, R. Chegwidden, 1978, Experientia.

Intracellular location of the autolytic N-acetylmuramyl-L-alanine amidase in Bacillus subtilis 168 and in an autolysis-deficient mutant by immunoelectron microscopy

J. Hobot, H. Rogers, 1991, Journal of bacteriology.

Failure of bupropion to affect tyramine response in man.

H. Rogers, R. Spector, A. W. Peck, 1983, The Journal of clinical psychiatry.

Failure of bupropion to affect the response to tyramine in man.

H. Rogers, R. Spector, A. W. Peck, 1981, British journal of clinical pharmacology.

Studies on the skeletal tissues. II. The collagen content of bones from rabbits, oxen and humans.

S M WEIDMANN, H. Rogers, H J ROGERS, 1952, The Biochemical journal.

Acetylator status and its relationship to breast cancer and other diseases of the breast.

P. Philip, R. Rubens, R. Millis, 1987, European journal of cancer & clinical oncology.

Acetylation and oxidation phenotypes in malignant lymphoma

P. Philip, P. Harper, H. Rogers, 2004, Cancer Chemotherapy and Pharmacology.

Determination of debrisoquine metabolic ratio from hourly urine collections in healthy volunteers.

P. Philip, H. Rogers, C. James, 1987, British journal of clinical pharmacology.

Further effects of chlorpromazine on the hexose permeability of the human erythrocyte

H. Rogers, G. Baker, 1973, The Journal of physiology.

Effects of psychotropic drugs on the erythrocyte permeability to glucose and ethylidene glucose.

H. Rogers, G. Baker, 1972, Biochemical pharmacology.

The complexity of the hyaluronidases produced by micro-organisms.

H. Rogers, 1948, The Biochemical journal.

Non‐linear pharmacokinetic behaviour of dapsone in the rabbit

H. Rogers, RaadA. Ahmad, 1981, The Journal of pharmacy and pharmacology.

COMPARISON OFTHE EFFECT OF DRUGS UPON SOME COMMONLY USED MEASURES OF BOWELTRANSITTIME

F. House, H. Rogers, I. Bradbrook, 2006 .

INTERACTION OF CIMETIDINE WITH TETRACYCLINE ABSORPTION

F. House, H. Rogers, P. Morrison, 1980, The Lancet.

PEPTIDOGLYCANS (MUCOPEPTIDES): STRUCTURE, FUNCTION, AND VARIATIONS

H. Rogers, H. Rogers, 1974, Annals of the New York Academy of Sciences.

The recognition of material present in horse muscle affecting the formation of alpha-toxin by a strain of Clostridium welchii.

H. Rogers, B. Knight, 1946, The Biochemical journal.

Comparison of radioimmunoassay and thin layer chromatographic assay methods for estimation of plasma prednisolone concentrations.

H. Rogers, W. Mcallister, S. Al-Habet, 1981, Journal of pharmacological methods.

Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.

I. Smith, R. Stuart-Harris, H. Rogers, 1985, British journal of cancer.

Urinary Excretion of Prednisolone Following Intravenous Administration in Humans

H. Rogers, Sayed M. H. Al‐Habet, 1989, Journal of clinical pharmacology.

The half-life of amitriptyline.

H. Rogers, I. Bradbrook, P. Morrison, 1978, British journal of clinical pharmacology.

Spherical and rod shaped protoplasts from β-lactam antibiotic treated cultures of Bacillus subtilis

H. Rogers, G. Wright, 1988 .

The Effect of Cerulenin on the Morphogenesis and Autolytic Activity of Bacillus subtilis

H. Rogers, P. Thurman, 1985 .

The relative bioavailability of paracetamol after rectal administration of suppositories containing a mixture of paracetamol, codeine phosphate and buclizine hydrochloride in healthy volunteers.

H. Rogers, A. Thomson, H. A. Burgess, 1985, Current medical research and opinion.

The effect of acetylator phenotype on the disposition of aminoglutethimide.

R. Rubens, S. Amiel, H. Rogers, 1984, British Journal of Clinical Pharmacology.

THE INTERRELATIONSHIP BETWEEN MUCOPEPTIDE AND RIBITOL TEICHOIC ACID FORMATION AS SHOWN BY THE EFFECT OF INHIBITORS.

A. J. Garrett, H. Rogers, 1965, The Biochemical journal.

A rapid method for determination of acetylation phenotype using dapsone.

P. Philip, M. Roberts, H. Rogers, 1984, British journal of clinical pharmacology.

Can once daily dosage be effective in the treatment of hypertension throughout 24 hours? A controlled evaluation of sustained release oxprenolol.

F. House, H. Rogers, G. N. Volan, 1979, British journal of clinical pharmacology.

Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.

H. Rogers, V. John, I. Bradbrook, 1982, British journal of clinical pharmacology.

Early changes in bacterial envelopes after inhibition of peptidoglycan synthesis, as shown by the use of a fluorescent probe.

H. Rogers, G. Wright, 1987, Journal of general microbiology.

Polymorphic N-acetylation capacity in lung cancer.

P. Philip, M. Peake, H. Rogers, 1988, Carcinogenesis.

Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection.

H. Rogers, C. James, 1986, Journal of chromatography.

ORG 10172: A lowmolecular weight heparinoid anticoagulant withalonghalf-life inman

H. Magnani, H. Rogers, I. Bradbrook, 1987 .

Magnesium and anion requirements of rodB mutants of Bacillus subtilis

R. Buxton, H. Rogers, P. Thurman, 1976, Journal of bacteriology.

Temperature-sensitive nature of the rodB maturation in Bacillus subtilis

H. Rogers, P. Thurman, 1978, Journal of bacteriology.

Wall and membrane growth in bacilli and their mutants.

H. Pooley, H. Rogers, P. Thurman, 1974, Annales de microbiologie.

Enhanced absorption of salicylate from Safapyryn-Co tablets.

H. Rogers, I. Bradbrook, P. Morrison, 1979, British journal of clinical pharmacology.

Two chromatographic methods for the determination of corticosteroids in human biological fluids: pharmacokinetic applications.

H. Rogers, S. Al-Habet, 1989, Journal of pharmaceutical sciences.

Effect of cimetidine on oral absorption of ampicillin and cotrimoxazole.

H. Rogers, C. James, I. Bradbrook, 1980, Journal of Antimicrobial Chemotherapy.

The hypotensive response to hydralazine, in triple therapy, is not related to acetylator phenotype.

H. Rogers, M. Vandenburg, R. Ahmad, 1982, British journal of clinical pharmacology.

Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjects.

H. Rogers, I. Bradbrook, P. Morrison, 1981, European journal of rheumatology and inflammation.

Effect of chlorpromazine on hexose penetration in the human erythrocyte.

H. Rogers, G. Baker, 1973, British journal of pharmacology.

Autolysins and shape change in rodA mutants of Bacillus subtilis

H. Rogers, C. Taylor, 1978, Journal of bacteriology.

The effects of some centrally acting drugs on the hexose transfer system in human erythrocytes

H. Rogers, G. Baker, 1973 .

First pass hepatic metabolism of cyclophosphamide [proceedings].

F. Juma, H. Rogers, J. Trounce, 1979, British Journal of Clinical Pharmacology.

THE BACTERIAL CELL WALL. THE RESULT OF ADSORPTION, STRUCTURE OR SELECTIVE PERMEABILITY?

H. Rogers, H J ROGERS, 1963, Journal of general microbiology.

Uroepithelial and nephrotubular toxicity in patients receiving ifosfamide/mesna: measurement of urinary N-acetyl-beta-D-glucosaminidase and beta-2-microglobulin.

L. Lewis, P. Harper, H. Rogers, 1992, European journal of cancer.

Concurrent administration of cimetidine and enteric-coated prednisolone: effect on plasma levels of prednisolone.

H. Rogers, I. Bradbrook, P. Morrison, 1980, British journal of clinical pharmacology.

ACUTE CARDIAC FAILURE DURING TREATMENT WITH DIGITOXIN-AN INTERACTION WITH RIFAMPICIN

H. Rogers, 2006 .